Bispecific antibodies
- 28 May 2021
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 372 (6545) , 916-917
Abstract
Bispecific antibodies have emerged as molecules with a multitude of talentsKeywords
This publication has 15 references indexed in Scilit:
- Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to DateBioDrugs, 2020
- Biology drives the discovery of bispecific antibodies as innovative therapeuticsAntibody Therapeutics, 2020
- On-target restoration of a split T cell-engaging antibody for precision immunotherapyNature Communications, 2019
- Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-OncologyClinical Cancer Research, 2019
- Bispecific antibodies: a mechanistic review of the pipelineNature Reviews Drug Discovery, 2019
- Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesmAbs, 2019
- Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3Science Translational Medicine, 2018
- Brain Shuttle Antibody for Alzheimer’s Disease with Attenuated Peripheral Effector Function due to an Inverted Binding ModeCell Reports, 2018
- The making of bispecific antibodiesmAbs, 2016
- A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A modelNature Medicine, 2012